A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.
Feb 26, 2015
4.4 / 5 (5) | 0
Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...
Feb 27, 2015
5 / 5 (2) | 0